Caprock Group LLC Makes New Investment in Intuitive Surgical, Inc. $ISRG

Caprock Group LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 9,194 shares of the medical equipment provider’s stock, valued at approximately $4,352,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Tobam grew its holdings in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 40 shares during the period. Kilter Group LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth $30,000. Finally, Guerra Advisors Inc purchased a new stake in Intuitive Surgical in the 3rd quarter worth $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on ISRG shares. Truist Financial boosted their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. HSBC raised their target price on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a research report on Monday, January 26th. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, January 21st. Finally, Robert W. Baird lowered their target price on shares of Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a research note on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $617.23.

Insider Activity

In other news, Director Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the sale, the director owned 15,720 shares of the company’s stock, valued at approximately $8,355,494.40. The trade was a 15.12% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mark Brosius sold 464 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the completion of the transaction, the senior vice president owned 131 shares of the company’s stock, valued at $71,852.19. The trade was a 77.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 56,189 shares of company stock worth $30,785,441 over the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Quarterly results and procedure growth support fundamentals. Intuitive reported a recent quarter that beat EPS and revenue estimates and showed high year‑over‑year revenue growth, and analysts continue to point to strong procedure trends and da Vinci 5 adoption — a fundamental driver that can support longer‑term revenue and system placements.
• Positive Sentiment: Industry commentary / analyst insights that highlight execution. Recent analyst notes (roundups) have discussed Intuitive alongside other healthcare names, keeping attention on the company’s execution and product cycle. Article Title
• Neutral Sentiment: Market data and charting reference. Interactive charting and market pages are being used by traders to monitor the pullback and technical levels (50‑day and 200‑day moving averages are near each other), supporting short‑term trading interest. Article Title
• Negative Sentiment: Executive insider selling disclosed this week. Multiple filings show senior executives (EVP Myriam Curet and VP Fredrik Widman) sold shares in early February, with some sales materially reducing their individual holdings — a near‑term negative signal for market sentiment. Filings: Myriam Curet SEC filing and Fredrik Widman SEC filing
• Negative Sentiment: Valuation debate / “priced for perfection” narrative. Commentary in the financial press is questioning whether ISRG’s valuation still assumes flawless execution after a recent pullback, raising investor caution around the stock’s premium multiple. Article Title
• Negative Sentiment: Recent share underperformance highlighted by analysts. Coverage notes that ISRG has fallen roughly mid‑double digits over the last three months despite ongoing procedure growth, which may have prompted short‑term selling pressure and re‑rating risk. Article Title
• Neutral Sentiment: Short interest data appears anomalous / not a clear driver. Recent short‑interest reports in the feed show zeros or NaN values and an effectively 0 days‑to‑cover figure — this looks like a data anomaly rather than confirmed heavy shorting, so it’s unlikely to be a meaningful market driver today.

Intuitive Surgical Stock Up 0.2%

Shares of NASDAQ:ISRG opened at $496.12 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $609.08. The stock has a market cap of $176.19 billion, a P/E ratio of 62.88, a PEG ratio of 3.84 and a beta of 1.65. The business has a fifty day moving average of $545.21 and a two-hundred day moving average of $510.52.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 EPS. The company’s revenue was up 18.8% compared to the same quarter last year. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.